26 employees
TranS1 develops a portfolio of medical products and intellectual property in the area of advanced surgical medicine.
2015
$12M
from 4 investors over 4 rounds
Trans1 raised $12M on May 12, 2003
Investors: Sapient Capital Partners, Cutlass Capital, Advanced Technology Ventures and Delphi Ventures